|
|||||||||
|
|
Guido Marcucci
Guido Marcucci, MD Research Interests Select Publications BAALC expression predicts clinical outcome of de novo acute myeloid leukemia patients with normal cytogenetics: a Cancer and Leukemia Group B study Whitman SP, Marcucci G, Caligiuri MA, de la Chapelle A, Bloomfield CD. Blood 102(5): 1613-1618, 2003. Characterization of leukemia-associated Core binding factor (CBF) primary acute myeloid leukemia: Is the molecular monitoring by RT-PCR useful clinically Marcucci G, Bloomfield CD, Caligiuri MA. Eur J Haematol 71(3): 143-154, 2003. Depsipeptide (FR 901228) promotes histone acetylation, gene transcription, apoptosis and its activity is enhanced by DNA methyltransferase inhibitors in AML1/ETO-positive leukemic cells Parthun MR, Whitman SP, Chan KK, Rush LJ, Plass C, Grever MR, Byrd JC, Marcucci G. Leukemia 17(2): 350-358, 2003. Depsipeptide (FR901228) induces histone acetylation and inhibition of histone deacetylase in chronic lymphocytic leukemia cells concurrent with activation of caspase-8-mediated apoptosis and downregulation of c-FLIP protein Parthun MR, Marcucci G, Grever MR, Byrd JC. Blood 102(2): 652-658, 2003. Depsipeptide (FR901228) inhibits proliferation and induces apoptosis in primary and metastatic human uveal melanoma cell lines Parthun MR, Marcucci G. Invest Ophthalmol Vis Sci 44(6): 2390-2398, 2003. Differential expression of histone post-translational modification in acute myeloid and chronic lymphocytic leukemia determined by high-pressure liquid chromatography and mass spectrometry Freitas MA, Parthun MR, Marcucci G, Byrd JC. J Am Soc Mass Spectrom 15(1): 77-86, 2003. Identification of thiols and glutathione conjugates of depsipeptide FK228 (FR901228), a novel histone protein deacetylase inhibitor in the blood Byrd JC, Marcucci G, Grever MR, Chan KK. Rapid Commun Mass Spectrom 17(8): 757-766, 2003. |
|
|
|
|
|